site sponsored by
Tag Archive | "biotech"
Tags: alzheimers, biotech, brain, disaster-spells, disease, florida, gamma-secretase, greengard, pathway-at-work, paul greengard, rudolph-tanzi, scientists-had, structure
Nobel Prize-winner finds new path for Alzheimer’s drug
Posted on 02 September 2010
Posted in Top NewsComments (0)
Tags: biotech, business-before, diagnostics, disease, greengard, morning, press, technology, units-generate, vernakalant
Cardiome shares jump after vernakalant OK triggers $30M milestone
Posted on 02 September 2010
Posted in Top NewsComments (0)
Tags: biotech, business-before, diagnostics, experts, greengard, japan, obesity, orexigen, orexigen therapeutics, press, units-generate, vernakalant
Orexigen and Takeda ink a billion-dollar pact on weight loss drug
Posted on 02 September 2010
Posted in Top NewsComments (0)
&h=57&w=100&zc=1&q=80" alt="Last call: Deadline looms for 2010 Fierce 15" class="th" />
Tags: biotech, count-the-votes, fierce, finishing, follow-the-link, great-science, over-the-next, private-biotech, recommendation, report, selection, started-writing, the-selection, year
Last call: Deadline looms for 2010 Fierce 15
Posted on 01 September 2010
Posted in Top NewsComments (0)
Tags: acute-myeloid, biotech, biotech venture capital, european, fierce, going-public, works-capital, year
Archimedes snags EMA approval for new pain therapy
Posted on 01 September 2010
Posted in Top NewsComments (0)
Tags: achaogen-which, acute-radiation, annenberg-hazen, biotech, cellerant therapeutics, devastating, development, marrow-or-cord, national, pursue-the-goal, rapidly-produce, rare diseases
Cellerant lands $153M BARDA contract for ARS program
Posted on 01 September 2010
Posted in Top NewsComments (0)
Tags: angeles-based, biotech, biotech deals, dermatologist, drug, emerging-drug, fully-leverage, intendis, leaving-tissue, localized-fat, reduction, strong-growth, the-aesthetic, under-the-chin
Bayer, Kythera ink $373M dermatology deal
Posted on 31 August 2010
Posted in Top NewsComments (0)
Tags: achaogen, biodefense, biotech, biotech deals, bubonic-plague, deals, development, gram-negative, under-the-chin
Achaogen wins $64M biodefense contract
Posted on 31 August 2010
Posted in Top NewsComments (0)
Tags: achaogen, amsterdam, article, biodefense, biotech, disorder-known, funding-options, glybera, Regulatory, under-the-chin
AMT looks for funding while it waits for EMA approval
Posted on 31 August 2010
Posted in Top NewsComments (0)
Tags: amsterdam, biotech, business, buying-partner, funding-options, health, lidoderm, sales
Endo looks for more acquisitions
Posted on 31 August 2010
Posted in Top NewsComments (0)
Ask Our Experts
Heather R. Powell
Regulatory
Dawn Obermoeller
Social Media
Jonathan Richman
Non-Personal Promotion
Optimize RX
Internet Marketing & Analytics
Share Your Knowledge
We are always seeking seasoned pharmaceutical marketing professonals as contributors. If you have a strong background in pharmacetical marketing, and are interested in sharing your skills and knowledge with our community, or syndicating your existing blog posts, please click here.
- Popular
- Latest
- Comments
- Tags
- Subscribe
- Women fleeing Wall Street. Does this apply to pharma as well ?
- Family Wins Fight Linking MMR Vaccine To Epilepsy
- adpharmnet: Random healthcare ads for inspiration - AdPharm http://ow.ly/2z6JA
- adpharmnet: Looking for ads for Alzheimer’s Disease? http://ow.ly/2z6Gv
- adpharmnet: Looking for competitive ads in the healthcare industry? Try searching on AdPharm http://ow.ly/2z4ae
- Yes, Roche Is Planning Those Job Cuts
- adpharmnet: Many new ads added today and throughout the week http://ow.ly/2z3A1
- adpharmnet: Neat typographic print ad for Partnerships in care - HCP print ad - UK - September 2010 http://ow.ly/2z3lm #advertising #healthcare #hcmktg
- My Journey From Obesity to Normal. First Stop: Stuck in Overweight!
- Metformin Against Cancer?
- Optimize RX: yep - recvd - thanks - how much daily u.v.'s r u g...
- JMB: This is another bashing article from an author who...
- Martin: It's just silly of you to obsess over the possibil...
- Gregg Feris: Jon, Thanks for the in depth reply. I like the ...
- Doc: Why should Exxon have to pay this fine for somethi...
2009
adpharm
adpharm gallery
advertising
alpha
biotech
bnet
branded
business
development
drug
DTC
english
europe
fda
fierce-biotech
fierce pharma
gallery
hcp
health
industry
internet
largest
marketing
motley-fool
News
north
north america
north_america
online
online-pharmaceutical
pharma
Print
print_ad
Regulatory
sales
seeking-alpha
single-page
Social Media
technology
the-gallery
the-largest
time
usa
wsj
Stay up to date
- Subscribe to the RSS Feed
